Cetuximab in combination with methotrexate (MTX) as first-line treatment in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): A phase Ib randomized phase II study versus single agent MTX

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; p. viii381
Main Authors	Ham, J., Meerten, E., Fiets, E., Jeurissen Mc Haaglanden, F., Slingerland, M., van der Graaf, W.T.A., van Herpen, C.M.L., Beerepoot, L.V.
Format	Journal Article
Language	English
Published	England Elsevier Ltd 01.10.2018
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdy287.024